Abbott Reports Fourth-Quarter and Full-Year 2022 Results; Issues 2023 Financial Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Abbott (ABT) tops consensus expectations despite decline in Covid-19 testing related sales
January 25, 2023 9:46 AM ESTAbbott (NYSE: ABT) shares fell Wednesday despite topping consensus expectations for profit and revenue.
The medical device firm reported adjusted fourth-quarter earnings of $1.03 per share, $0.11 better than the analyst estimate of $0.92.
Revenue for the quarter came in at $10.1 billion versus the consensus estimate of $9.62 billion.... More
Abbott (ABT) Tops Q4 EPS by 11c, Revenues Beat
January 25, 2023 7:31 AM ESTAbbott (NYSE: ABT) reported Q4 EPS of $1.03, $0.11 better than the analyst estimate of $0.92. Revenue for the quarter came in at $10.1 billion versus the consensus estimate of $9.62 billion.
GUIDANCE:
Abbott sees FY2023 EPS of $4.30-$4.50, versus the consensus of $4.40.
For earnings history and earnings-related data on Abbott (ABT) click here.
... More